Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson's disease.

The Kelch-like ECH-associated protein 1 (Keap1)-Nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway plays a pivotal role in the cellular defense system against oxidative stress by inducing antioxidant and anti-inflammatory effects. We previously developed Nrf2 activators that potentially protect the death of dopaminergic (DAergic) neuronal cells against oxidative stress in Parkinson's disease (PD). In this study, we designed and synthesized a class of halogenated vinyl sulfones by inserting halogens and pyridine to maximize Nrf2 activation efficacy. Among the synthesized compounds, (E)-3-chloro-2-(2-((2-chlorophenyl)sulfonyl)vinyl)pyridine (9d) significantly exhibited potent Nrf2 activating efficacy (9d: EC50 = 26 nM) at least 10-fold compared with the previous developed compounds (1 and 2). Furthermore, treating with 9d remarkably increased Nrf2 nuclear translocation and Nrf2 protein levels in microglial BV-2 cells. 9d was shown to induce the expression of antioxidant response genes HO-1, GCLC, GCLM, and SOD-1 at both the mRNA and protein levels and suppress proinflammatory cytokines and enzymes. Also, 9d remarkably protected DAergic neurons and restored the PD-associated motor dysfunction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model. Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Citation

Ji Won Choi, Siwon Kim, Jong Seok Yoo, Hyeon Jeong Kim, Hyeon Ji Kim, Byung Eun Kim, Elijah Hwejin Lee, Yong Sup Lee, Jong-Hyun Park, Ki Duk Park. Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson's disease. European journal of medicinal chemistry. 2021 Feb 15;212:113103

Mesh Tags

Substances

PMID: 33387904

search → result